Brian Daly

Title: Innovations in Immunologic Tolerance: The Work of Brian Daly

Introduction

Brian Daly is an accomplished inventor based in Edmonton, Ireland. He has made significant contributions to the field of immunology, particularly in the area of inducing immunologic tolerance to non-self antigens. His innovative approaches have the potential to transform transplant medicine and improve patient outcomes.

Latest Patents

Brian Daly holds a patent for "Methods and systems for inducing immunologic tolerance to non-self antigens." This patent describes methods and systems that can be utilized to induce immunologic tolerance to non-self antigens. The methods involve introducing a tolerogen that comprises at least one immunogenic non-self antigen coupled to a carrier. The immunogenic antigen can be a foreign or endogenous antigen or fragments thereof. The non-self antigen can be selected from carbohydrate antigens, full-length antigenic proteins, and fragments and combinations thereof. The carrier can be selected from nanoparticles and stents. The tolerogen compositions provided can be used to induce immunologic tolerance to non-self antigens, which is particularly advantageous for extending the window of safety for immunologically-incompatible transplantations in patients beyond infancy.

Career Highlights

Brian Daly is affiliated with the University of Alberta, where he conducts research and develops innovative solutions in immunology. His work has garnered attention for its potential applications in improving transplant success rates and patient safety.

Collaborations

Brian collaborates with notable colleagues, including Lori Jeanne West and Todd Lambert Lowary. Their combined expertise enhances the research efforts and contributes to advancements in the field.

Conclusion

Brian Daly's innovative work in immunologic tolerance represents a significant advancement in medical science. His contributions have the potential to improve the lives of many patients facing transplant challenges.